Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management Abhiram Kumar et al, 2022, Frontiers in Nutrition CrossRef
Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway Zhen-yu Ma et al, 2023, Cytokine & Growth Factor Reviews CrossRef
Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk Vanessa Bianconi et al, 2018, Current Cardiology Reports CrossRef
Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy
Xiao Ke et al, 2020, Drug Design, Development and Therapy CrossRef
Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity Qingxuan Zeng et al, 2021, Journal of Medicinal Chemistry CrossRef
Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology Xuejiao Xie et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine Yun Cai et al, 2021, Frontiers in Pharmacology CrossRef
Rhizoma Coptidis for Alzheimer’s Disease and Vascular Dementia: A Literature Review Zhiyong Wang et al, 2020, Current Vascular Pharmacology CrossRef
Visfatin Amplifies Cardiac Inflammation and Aggravates Cardiac Injury via the NF-κB p65 Signaling Pathway in LPS-Treated Mice Yewen Hu et al, 2022, Mediators of Inflammation CrossRef
Natural drugs targeting inflammation pathways can be used to treat atherosclerosis Xiayinan Song et al, 2022, Frontiers in Pharmacology CrossRef
Effects of Systemic Simvastatin on the Concentrations of Visfatin, Tumor Necrosis Factor-α, and Interleukin-6 in Gingival Crevicular Fluid in Patients with Type 2 Diabetes and Chronic Periodontitis Maha A. Bahammam et al, 2018, Journal of Immunology Research CrossRef
Effects of Berberine on Atherosclerosis Rui Rui et al, 2021, Frontiers in Pharmacology CrossRef